Search General Info
Search Education
Search Partnering Companies
photo
Speaker

Marianne De Backer, PhD, MBA

MEMBER OF THE EXECUTIVE COMMITTEE, EXECUTIVE VICE PRESIDENT AND HEAD OF STRATEGY, BUSINESS DEVELOPMENT AND LICENSING, BAYER PHARMACEUTICALS, BAYER AG
Berlin, Germany
Dr. De Backer has been a strategist, scientist, business leader, deal maker and corporate investor in the healthcare industry for more than two decades. She has been directly accountable for more than 200 strategic alliances in healthcare, some of which have led to newly approved medicines now available to patients. Dr. De Backer is currently chief business officer and executive vice president, Strategy and Business Development and Licensing, at Bayer AG, and a member of the Executive Committee of Bayer Pharmaceuticals. Before joining Bayer in 2019, she spent more than 20 years at the Johnson & Johnson family of companies. She started as a scientist and scientific group leader, during which time her work resulted in multiple patents. She progressed through commercial positions internationally, including leading a sales and marketing business unit responsible for several therapies, culminating as senior vice president, M&A Operations, Divestitures and Janssen Business Development. She currently serves on the boards of directors of the Gladstone Foundation and Arrowhead Pharmaceuticals. Dr. De Backer holds an M.S. in molecular biology from the Vrije Universiteit Brussels, an M.S. in engineering and biochemistry and a Ph.D. in biotechnology from the University of Ghent, and an MBA from the Rotterdam School of Management at Erasmus University.
Speaking In
12:45 PM - 1:30 PM (EDT)
Tuesday, June 15

Dealmakers adjusted to the new landscape of remote work and navigating a global health crisis in…